126 related articles for article (PubMed ID: 1535579)
1. Macrolide pharmacokinetics and dose scheduling of roxithromycin.
Nilsen OG; Aamo T; Zahlsen K; Svarva P
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):71S-76S. PubMed ID: 1535579
[TBL] [Abstract][Full Text] [Related]
2. Penetration of roxithromycin into gingival tissue.
Jehl F; Kolbe R; Scheimberg A; Rosembaum M; Monteil H
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):77S-79S. PubMed ID: 1617928
[TBL] [Abstract][Full Text] [Related]
3. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans.
Fraschini F; Scaglione F; Pintucci G; Maccarinelli G; Dugnani S; Demartini G
J Antimicrob Chemother; 1991 Feb; 27 Suppl A():61-5. PubMed ID: 1827103
[TBL] [Abstract][Full Text] [Related]
4. Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing.
Birkett DJ; Robson RA; Grgurinovich N; Tonkin A
Ther Drug Monit; 1990 Jan; 12(1):65-71. PubMed ID: 2305423
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interactions between erythromycin, clarithromycin, roxithromycin and phenytoin in the rat.
al-Humayyd MS
Chemotherapy; 1997; 43(2):77-85. PubMed ID: 9084915
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics of clarithromycin granule and tablet in children].
Motohiro T; Yoshinaga Y; Sasaki H; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Sakata Y
Jpn J Antibiot; 1989 Feb; 42(2):465-94. PubMed ID: 2526257
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of macrolides. Comparison of plasma, tissue and free concentrations with special reference to roxithromycin.
Nilsen OG
Infection; 1995; 23 Suppl 1():S5-9. PubMed ID: 7782117
[TBL] [Abstract][Full Text] [Related]
8. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
Bahal N; Nahata MC
Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
[TBL] [Abstract][Full Text] [Related]
9. [Relative bioavailability of roxithromycin dispersive tablets in healthy volunteers].
Huang T; Li T; Yang L; Xu X; Zheng P; Zhang T; Zheng J; Chen S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Apr; 24(2):376-8. PubMed ID: 17591264
[TBL] [Abstract][Full Text] [Related]
10. Roxithromycin Pharmacokinetics in Hospitalized Geriatric Patients: Oral Administration of Whole Versus Crushed Tablets.
Britzi M; Berkovitch M; Soback S; Leibovitz A; Segal R; Smagarinsky M; Lubart E
Ther Drug Monit; 2015 Aug; 37(4):512-5. PubMed ID: 26186658
[TBL] [Abstract][Full Text] [Related]
11. Female genital tissue concentrations of roxithromycin.
Furneri PM; Pinizzotto MR; Rugolo S; Cianci S; Cianci A; Tempera G
J Chemother; 1991 Jan; 3 Suppl 1():30-2. PubMed ID: 12041780
[TBL] [Abstract][Full Text] [Related]
12. [Tissue penetration properties of macrolide antibiotics--comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats].
Yoshida H; Furuta T
Jpn J Antibiot; 1999 Jul; 52(7):497-503. PubMed ID: 10516929
[TBL] [Abstract][Full Text] [Related]
13. Disposition of roxithromycin in patients with normal and severely impaired renal function.
Halstenson CE; Opsahl JA; Schwenk MH; Kovarik JM; Puri SK; Ho I; Matzke GR
Antimicrob Agents Chemother; 1990 Mar; 34(3):385-9. PubMed ID: 2334149
[TBL] [Abstract][Full Text] [Related]
14. [Basic and clinical studies on clarithromycin in pediatrics].
Iwai N; Taneda Y; Miyazu M; Nakamura H; Kasai K
Jpn J Antibiot; 1989 Feb; 42(2):304-22. PubMed ID: 2526244
[TBL] [Abstract][Full Text] [Related]
15. Roxithromycin disposition in patients on continuous ambulatory peritoneal dialysis.
Lam YW; Flaherty JF; Yumena L; Schoenfeld PY; Gambertoglio JG
J Antimicrob Chemother; 1995 Jul; 36(1):157-63. PubMed ID: 8537262
[TBL] [Abstract][Full Text] [Related]
16. Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial.
Chu S; Park Y; Locke C; Wilson DS; Cavanaugh JC
J Clin Pharmacol; 1992 Jan; 32(1):32-6. PubMed ID: 1531484
[TBL] [Abstract][Full Text] [Related]
17. Disposition of roxithromycin in the epididymis after repeated oral administration.
Costa P; Desclaux d'Arramon F; Gouby A; Navratil H; Geny F; Galtier M; Bressolle F
J Antimicrob Chemother; 1992 Aug; 30(2):197-201. PubMed ID: 1399928
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of rheumatic fever prophylaxis regimens.
Thamlikitkul V; Kobwanthanakun S; Pruksachatvuthi S; Lertluknithi R
J Int Med Res; 1992 Feb; 20(1):20-6. PubMed ID: 1568517
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and disposition of clarithromycin in man.
Ferrero JL; Bopp BA; Marsh KC; Quigley SC; Johnson MJ; Anderson DJ; Lamm JE; Tolman KG; Sanders SW; Cavanaugh JH
Drug Metab Dispos; 1990; 18(4):441-6. PubMed ID: 1976065
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination and pharmacokinetic study of roxithromycin and ambroxol hydrochloride in human plasma by LC-MS/MS.
Hang TJ; Zhang M; Song M; Shen JP; Zhang YD
Clin Chim Acta; 2007 Jul; 382(1-2):20-4. PubMed ID: 17462615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
